Clinical Trial Update: A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants [Phase 3]

View source ↗

Summary

Phase III trial update for a 13-valent pneumococcal conjugate vaccine in healthy infants completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• 13-valent pneumococcal conjugate vaccine (13-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Pneumonia | Phase 3 | Status: COMPLETED